These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12710390)

  • 21. Controlling blood pressure. Cheaper may be better.
    Mayo Clin Health Lett; 2003 Jun; 21(6):4-5. PubMed ID: 12793366
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The restriction of salt intake for therapy of essential hypertension].
    Nomura G
    Nihon Rinsho; 1992 May; 50 Suppl():143-8. PubMed ID: 1512950
    [No Abstract]   [Full Text] [Related]  

  • 24. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.
    Campese VM
    Am J Kidney Dis; 2007 Aug; 50(2):197-202. PubMed ID: 17660021
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Krut LH
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846227
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Pickering TG
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12840099
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
    Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
    Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.
    Grimm R
    Am J Kidney Dis; 2007 Aug; 50(2):188-96. PubMed ID: 17660020
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Reese AM; Talbert RL; Bussey HI
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846228
    [No Abstract]   [Full Text] [Related]  

  • 32. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 33. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics.
    Mogensen CE
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S15-20. PubMed ID: 16075028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
    Nicholls MG
    J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
    [No Abstract]   [Full Text] [Related]  

  • 38. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
    Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treating hypertension is more important than the choice of agent; results from the largest clinical trial until now].
    de Leeuw PW; Birkenhäger WH
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):685-9. PubMed ID: 12722529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
    Conlin PR
    Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.